An Indian-origin chief financial officer, Aditya Humad, has been sentenced to a four-month prison term by a US federal court for his central role in a healthcare bribery scheme, federal authorities announced. Humad, a 41-year-old resident of Cambridge, Massachusetts, previously pleaded guilty to one count of conspiracy to violate the federal anti-kickback statute. Following his period of incarceration, he will be placed on one year of supervised release and pay a court-ordered fine of USD 9,500.
Details of the Sham Consulting Fee Scheme
Humad was charged in September 2021 alongside Kingsley R. Chin, the founder, president, and chief executive officer of medical device company SpineFrontier, Inc. According to statements from the US Attorney’s Office for the District of Massachusetts, Humad conspired to direct over USD 540,000 in bribes to orthopedic and neurological surgeons, disguised under the guise of sham consulting fees for work that was never actually performed.
Under contracts executed by Humad and SpineFrontier, participating surgeons were purportedly paid between USD 250 and USD 1,000 per hour to provide technical feedback and consulting on the company’s spinal implant products. In reality, prosecutors established that surgeons spent only a small fraction of their reported time, if any, performing legitimate consulting work. In exchange for these financial kickbacks, the surgeons used SpineFrontier products in complex procedures, generating millions of dollars in corporate revenue.
Federal Recovery Exceeds Four Million Dollars
United States Attorney Leah B. Foley noted that the sentencing represents the culmination of years of investigation into SpineFrontier, its executive leadership, and multiple participating physicians. Foley confirmed that federal authorities have recovered over USD 4 million across parallel criminal and civil proceedings against the involved corporate officers, entities, and bribed surgeons.
Federal law enforcement emphasized that these legal resolutions serve as an explicit warning that authorities will crack down on sophisticated healthcare fraud offences regardless of how long the investigation takes.
Federal officials highlighted that the illicit kickback scheme directly involved surgical procedures paid for by taxpayer-funded healthcare programs, including Medicare, Medicaid, and the Veterans Health Administration.
Roberto Coviello, Special Agent in Charge at the US Department of Health and Human Services Office of Inspector General, stated that paying corporate bribes to influence medical device selection corrupts clinical judgment. Coviello emphasized that Humad’s actions actively undermined critical regulatory safeguards designed to protect patient health and preserve the integrity of public healthcare funding.
